HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of the effects of trimebutine and YM114 (KAE-393), a novel 5-HT3 receptor antagonist, on stress-induced defecation.

Abstract
YM114 (KAE-393), (R)-5-[(2,3-dihydro-1-indolyl)carbonyl]-4,5,6,7- tetrahydro-1H-benzimidazole hydrochloride, is a derivative of YM060, a potent 5-HT3 receptor antagonist. We investigated the effects of YM114 on 5-HT3 receptors, both in vitro and in vivo, and on bowel dysfunction induced by restraint stress, 5-HT and thyrotropin-releasing hormone (TRH), and compared them with the effect of trimebutine. YM114 dose dependently inhibited the reduction in heart rate induced by 5-HT (30 micrograms/kg i.v.) in rats (ED50 = 0.31 micrograms/kg i.v.), and the potency of YM114 was almost the same as that of the racemate. The S-form of YM114 also inhibited 5-HT-induced bradycardia, but 1350 times less potent than the R-form. YM114 and its S-form inhibited [3H]GR65630 binding to N1E-115 cell membranes in a concentration-dependent manner with Ki values of 0.341 and 616 nM, respectively, showing the isomeric activity ratio (R-/S-form) of YM114 to be much greater (1800). YM114 antagonized 5-HT-induced depolarization of the nodose ganglion (EC50 = 1.39 nM). Trimebutine (1 mg/kg i.v.) failed to inhibit 5-HT-induced bradycardia, implying that it does not possess 5-HT3 receptor antagonistic activity. YM114 significantly and dose dependently prevented restraint stress-, 5-HT- and TRH-induced increases in fecal pellet output, and restraint stress- and 5-HT-induced diarrhea in rats and mice (ED50 = 6.9, 72.5, 154.6, 9.7 and 52.4 micrograms/kg p.o., respectively). Trimebutine significantly prevented stress- and 5-HT-induced diarrhea (ED50 = 29.4 and 87.3 mg/kg p.o., respectively), but only partially affected stress-, 5-HT- and TRH-induced increases in fecal pellet output. Thus, YM114 is a potent and stereoselective 5-HT3 receptor antagonist with much greater protective effects against stress-induced defecation than trimebutine.
AuthorsK Miyata, H Ito, M Yamano, K Hidaka, T Kamato, A Nishida, H Yuki
JournalEuropean journal of pharmacology (Eur J Pharmacol) Vol. 250 Issue 2 Pg. 303-10 (Dec 07 1993) ISSN: 0014-2999 [Print] Netherlands
PMID8112388 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Benzimidazoles
  • Imidazoles
  • Indoles
  • Serotonin Antagonists
  • GR 65630
  • YM 114
  • Serotonin
  • Thyrotropin-Releasing Hormone
  • Castor Oil
  • Dinoprostone
  • Trimebutine
Topics
  • Animals
  • Benzimidazoles (pharmacology)
  • Castor Oil
  • Cell Membrane (drug effects, metabolism)
  • Defecation (drug effects)
  • Diarrhea (chemically induced, prevention & control)
  • Dinoprostone (pharmacology)
  • Heart Rate (drug effects)
  • Imidazoles (pharmacokinetics)
  • Indoles (pharmacokinetics)
  • Male
  • Mice
  • Mice, Inbred ICR
  • Nodose Ganglion (drug effects)
  • Rabbits
  • Rats
  • Rats, Wistar
  • Serotonin (pharmacology)
  • Serotonin Antagonists
  • Stress, Psychological (psychology)
  • Thyrotropin-Releasing Hormone (pharmacology)
  • Trimebutine (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: